Choudhry v. Mead Johnson & Co., 2026 WL 2349932, No. 25-cv-09480
(ER) (S.D.N.Y. Aug. 13, 2026)
Plaintiffs alleged that various Enfamil infant formulas
contained arsenic, cadmium, and lead, heavy metals that present significant health
risks, particularly to young children, and “can cause serious and often
irreversible damage to brain development,” including from “low levels of
exposure.” They sued for false advertising under NY law.
They allegedly relied on the following claims on the
packaging: “ ‘Brain Building,’ ‘#1 Recommended Brand by Pediatricians,’ ‘The
Only Hypoallergic [sic] Formula With LGG® Probiotic,’ ‘No Artificial Growth
Hormones,’ ‘LGG® probiotic to help support digestive health’ and ‘does not use
table sugar,’ ” along with “expert recommended,” and some others. They alleged
that reasonable consumers would not think these products contained heavy
metals.
A consumer survey conducted by their counsel found that
77.8% of survey participants answered “No” when asked, “After seeing the label
would you expect arsenic, cadmium, lead, and/or mercury in the infant formula?”
The survey followed up:, “how important, if at all, would it be to your
purchasing decision if the infant formula you purchased contained, or risked
containing, even a small amount of arsenic, cadmium, lead, and/or mercury,” and
71.0% of participants answered “Very important,” 25.4% “Important,” and 3.6%
“Not at all important.” Mead Johnson received judicial notice for the fact that,
“[i]n April 2026, the FDA released a report finding low levels of Heavy Metals
in many infant formulas, cautioned that this was not automatically reason for
alarm, and that additional guidance is forthcoming, but did not provide a
timeline for that guidance.”
The court declined to apply the primary jurisdiction
doctrine. White v. Beech-Nut Nutrition Co., 2024 WL 194699 (2d Cir. Jan. 18,
2024) vacated the district court’s dismissal of a similar case based on the
primary jurisdiction doctrine; detailed consideration wasn’t required because “the
FDA had no expected timeline to provide actionable guidance on the safe levels
of Heavy Metals in infant formulas, which outweighed ‘any advantages of
deferring to the FDA under the primary jurisdiction doctrine.’” That was still
true.
Also, courts are well-suited to determine if a product’s
packaging was misleading or deceptive. This case didn’t require the court to
determine what levels of heavy metals should be permissible, so there is not “a
substantial danger of inconsistent rulings.”
Standing for unpurchased products: although the ingredients
weren’t identical, the same alleged misrepresentation was on all of them, which
was enough at this stage.
GBL §§ 349 and 350: Not subject to 9(b) pleading requirements.
Mead Johnson questioned plaintiffs’ reliance, but they alleged that they “read
and relied upon the packaging of the Infant Formulas when making their
purchasing decisions,” which sufficed.
Material misleadingness to “a significant portion of the
general consuming public or of targeted customers, acting reasonably in the
circumstances”: Courts will not permit such claims “where the plaintiffs’
alleged inference appeared fundamentally incompatible with basic common sense.”
Plaintiffs didn’t allege that the formulas advertised that they didn’t have
heavy metals, “but that the packaging misleadingly represented the products as
healthy, safe, and nutritious when they contained or risked containing Heavy
Metals,” with claims like “Brain Building,” “expert recommended,” and “#1
Recommended Brand by Pediatricians.” The court agreed that the survey bolstered
this inference.
Interesting comment:
Plaintiffs’ pleading satisfies this
low burden because it demonstrates that the majority of consumers would
assume the product did not contain Heavy Metals based on its label. This does
not definitively establish that a reasonable consumer would be misled by
the packaging. However, at this stage, despite certainly requiring an
inferential leap, Plaintiffs sufficiently allege that this supposed deception
is not “patently implausible” such that the Court can determine as a matter of
law that reasonable consumers could not be misled by the packaging. (emphasis
added)
Is the court saying that a majority of consumers could still
be unreasonable? Empirical v. normative claims about reasonable consumers are
scattered throughout cases, with courts rarely articulating the relationship
between “reasonable” and “common.”
Anyway, implicit misrepresentation was plausible. What about
an omission theory? Mead Johnson argued
that plaintiffs failed to allege that knowledge about heavy metals was solely
in its possession and that consumers could not obtain the information, and also
that heavy metals in food is widely known.
At the motion to dismiss stage, “a plaintiff bringing an
omission-based claim for § 349 liability must show that ‘the business alone
possesses material information that is relevant to the consumer and fail[ed] to
provide this information,’ or that plaintiffs could not ‘reasonably have
obtained the relevant information they now claim the [defendant] failed to
provide.’ ” This was sufficiently alleged. Plaintiffs alleged Mead Johnson’s
superior knowledge; that consumers reasonably expected Mead Johnson to test for
heavy metals and disclose that information to the public; that Mead Johnson
deceptively hid that it failed to monitor for the presence of heavy metals in
its products; and that consumers could not detect their presence without
conducting scientific tests.
Materiality to a reasonable consumer: not a separate
element, but it would be reasonable to assume that heavy metals’ presence would
be material because of their health risks.
For common law fraudulent misrepresentation, Mead Johnson
argued that its efforts as part of a trade organization to lobby against a
California bill that would require disclosure of heavy metals content was
insufficient to plead scienter because it is “legitimate First Amendment
activity,” not “conscious misbehavior.” That alone wasn’t sufficient to
establish the required “strong circumstantial evidence” of scienter, but it
could bolster the claims.
However, unjust enrichment was dismissed as duplicative.
No comments:
Post a Comment